Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Durect Corporation (DRRX)

« Back to company index

DRRX Chatter Timeline

Stock Ticker for DRRX

Most Active Tweeters for DRRX

UserTweets
@BlueBioNow 5
@Gambiste1 5
@AmericanBanking 4
@newsfilterio 3
@TickerReport 3

Recent Tweets for DRRX

BioBreakout @BioBreakout
$DRRX Bollinger Band Sqeeeeeze... https://t.co/YjRcNbYg8s
November 10th 2019, 3:11pm
Gambiste1 @Gambiste1
RT @Tommycoulter4: Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/7Grxs3cB6j
November 10th 2019, 2:11pm
Gambiste1 @Gambiste1
RT @stocks_sports: Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/oL63VQauFI
November 10th 2019, 2:11pm
Tommycoulter4 @Tommycoulter4
Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/7Grxs3cB6j
November 10th 2019, 2:11pm
stocks_sports @stocks_sports
Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/oL63VQauFI
November 10th 2019, 2:11pm
WeekHerald @WeekHerald
DURECT Co. $DRRX Expected to Announce Quarterly Sales of $10.38 Million https://t.co/2mKcJgUGJn
November 10th 2019, 6:11am
OlympiaReport @OlympiaReport
Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Post Quarterly Sales of $10.38 Million https://t.co/63Hq0hYkj4
November 10th 2019, 6:11am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Post Quarterly Sales of $10.38 Million https://t.co/eSxHQUo7TB #stocks
November 10th 2019, 6:11am
BlueBioNow @BlueBioNow
$DRRX substantial stock price changes 2.15 % change recently https://t.co/7HeBMHCdbk
November 10th 2019, 3:11am
WatchlistN @WatchlistN
-$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/OACelkY3HA
November 8th 2019, 5:11pm
TickerReport @TickerReport
-$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/YB8DVHrhhe
November 8th 2019, 5:11pm
AmericanBanking @AmericanBanking
-$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/z40Admw6dc #stocks
November 8th 2019, 5:11pm
chartseer @chartseer
RT @kkernttb: $DRRX a nice looking small cap setup... nice coil and expanding volume last hour or so https://t.co/9mM4m4Khdb
November 8th 2019, 3:11pm
kkernttb @kkernttb
$DRRX a nice looking small cap setup... nice coil and expanding volume last hour or so https://t.co/9mM4m4Khdb
November 8th 2019, 3:11pm
Gambiste1 @Gambiste1
RT @jjokerst: $DRRX coiling prior to 11/12 phase 2 data release for alcoholic hepatitis treatment. #fda
November 7th 2019, 10:11pm
jjokerst @jjokerst
$DRRX coiling prior to 11/12 phase 2 data release for alcoholic hepatitis treatment. #fda
November 7th 2019, 8:11pm
newsfilterio @newsfilterio
Durect EPS beats by $0.01, beats on revenue $DRRX https://t.co/3RjfDAWBy6
November 7th 2019, 3:11pm
newsfilterio @newsfilterio
DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs $DRRX https://t.co/zDMBYuQFEc
November 7th 2019, 2:11pm
dispatchtribune @dispatchtribune
DURECT $DRRX Issues Earnings Results, Misses Expectations By $0.03 EPS https://t.co/YbFTgtFlfF
November 7th 2019, 12:11pm
EnterpriseLeade @EnterpriseLeade
DURECT $DRRX Issues Earnings Results https://t.co/2aazpvtZXT
November 7th 2019, 11:11am
bmarckxCFA @bmarckxCFA
$DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/uqjHGO2u5m via @YahooFinance
November 7th 2019, 8:11am
Gambiste1 @Gambiste1
RT @knackchamp: $DRRX Nice consolidation period, RSI and CCI showing uptrend. This could see 2.40+ on break of 2.05 area. #TradeSmart https…
November 7th 2019, 1:11am
knackchamp @knackchamp
$DRRX Nice consolidation period, RSI and CCI showing uptrend. This could see 2.40+ on break of 2.05 area.… https://t.co/KQKLoLLMKV
November 7th 2019, 12:11am
AlertTrade @AlertTrade
RT @Briefingcom: $DRRX: Durect to host key opinion leader conference call and live webcast to discuss results of its recently... https://t.…
November 6th 2019, 7:11pm
Briefingcom @Briefingcom
$DRRX: Durect to host key opinion leader conference call and live webcast to discuss results of its recently... https://t.co/MPruAVYedp
November 6th 2019, 7:11pm
newsfilterio @newsfilterio
DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results $DRRX https://t.co/0USGnTA2kg
November 6th 2019, 7:11pm
MaisaCorp @MaisaCorp
$DRRX Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study ResultsCall will feature data from… https://t.co/sgRMPH4H9k
November 6th 2019, 7:11pm
ProTradersNews @ProTradersNews
$DRRX: DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a …: https://t.co/rARTkDyqB1
November 6th 2019, 6:11pm
otcdynamics @otcdynamics
$DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/UeMWbQKU2l
November 6th 2019, 6:11pm
ez_alertz @ez_alertz
$DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/TEk5ADyzUr
November 6th 2019, 5:11pm
VGaykin @VGaykin
RT @TraderTexMex: $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results Nov 12th at 830am
November 6th 2019, 5:11pm
TraderTexMex @TraderTexMex
$DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results Nov 12th at 830am
November 6th 2019, 5:11pm
ZolmaxNews @ZolmaxNews
DURECT $DRRX Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/aeNo5hk4EW
November 6th 2019, 10:11am
Gambiste1 @Gambiste1
RT @LifeSciAdvisors: DURECT Corporation $DRRX Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/wIsIAJECSW
November 5th 2019, 6:11pm
LifeSciAdvisors @LifeSciAdvisors
DURECT Corporation $DRRX Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/wIsIAJECSW
November 5th 2019, 12:11pm
WeekHerald @WeekHerald
DURECT $DRRX Releases Earnings Results, Misses Estimates By $0.03 EPS https://t.co/gJDvgwjxg6
November 5th 2019, 11:11am
bbnsnews @bbnsnews
DURECT $DRRX Posts Earnings Results, Misses Expectations By $0.03 EPS https://t.co/6qqXcbAZzh
November 5th 2019, 11:11am
TickerReport @TickerReport
DURECT $DRRX Announces Earnings Results, Misses Estimates By $0.03 EPS https://t.co/Ul6OJIgRP5
November 5th 2019, 10:11am
AmericanBanking @AmericanBanking
DURECT $DRRX Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/D97QB9ddxe #stocks
November 5th 2019, 9:11am
ConsumerFeed @ConsumerFeed
DURECT $DRRX Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/LbK43HZd9p
November 5th 2019, 9:11am
BlueBioNow @BlueBioNow
$DRRX might be worth taking a position when this bottoms 4.08 % change recently https://t.co/7HeBMHCdbk
November 5th 2019, 6:11am
SiteFocusHQ @SiteFocusHQ
$DRRX Earnings Intelligence Analysis of recent earnings identified Durect Corporation (NASDAQ: DRRX ) business focu… https://t.co/EOv19bukrH
November 4th 2019, 11:11pm
StockNewsNow @StockNewsNow
$DRRX DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/yLCqXg2i0R
November 4th 2019, 11:11pm
ProTradersNews @ProTradersNews
$DRRX: DURECT Corp (DRRX) CEO James Brown on Q3 2019 Results …: https://t.co/SX7sWcJC8r
November 4th 2019, 10:11pm
SeekingAlpha @SeekingAlpha
$DRRX - DURECT Corp (DRRX) CEO James Brown on Q3 2019 Results - Earnings Call Transcript. Read more and get updates… https://t.co/KFzyhBaEbW
November 4th 2019, 9:11pm
Stock_News_Now @Stock_News_Now
$DRRX: New SEC Filing for DRRX: Form 8-K (No. 0001564590-19-039797): https://t.co/jklLqpkm5z
November 4th 2019, 4:11pm
MaisaCorp @MaisaCorp
$DRRX have completed enrollment in a Phase 2a, randomized, double-blind, vehicle-controlled proof-of-concept clinic… https://t.co/YQkU3990zg
November 4th 2019, 4:11pm
otcdynamics @otcdynamics
$DRRX DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/evVXkxOSKT
November 4th 2019, 4:11pm
ProVesting @ProVesting
$DRRX: DURECT Corporation Announces Third Quarter 2019 Financial …: https://t.co/tst3PDxuf0
November 4th 2019, 4:11pm
MarketCurrents @MarketCurrents
$DRRX - Durect EPS beats by $0.01, beats on revenue https://t.co/UfvtU2gXkS
November 4th 2019, 4:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.